Walgreen Co. and CVS Caremark Corp. (CVS) have announced plans to start selling a fertility test for men, complementing kits now available for women.
The drugstores will begin selling the SpermCheck Fertility test, which can determine if a man is producing enough sperm to impregnate a woman, according to Bloomberg News.
The $40 test should be available in stores in April.
The test, owned and distributed by ContraVac Inc., comes in a blue-and-gold box and features a smiling couple holding a newborn.
It will add to the nearly two dozen varieties of female fertility tests available in stores and fill a longstanding gap between male and female fertility tests.
Walgreens and CVS now sell SpermCheck Fertility online.
According to the Centers for Disease Control and Prevention, about 7.3 million women in the U.S. have trouble with pregnancies each year.